Skip to main content
  • Book
  • © 2006

Immunotherapy of Cancer

Editors:

Part of the book series: Cancer Drug Discovery and Development (CDD&D)

Buy it now

Buying options

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (28 chapters)

  1. Interleukin-2 as Cancer Therapy

    • Joseph I. Clark, Kim A. Margolin
    Pages 355-364
  2. Biological and Clinical Properties of the Type 1 Interferons

    • Douglas W. Leaman, Shaun Rosebeck, Ernest C. Borden
    Pages 365-396
  3. Promising γ-Chain Cytokines for Cancer Immunotherapy

    • Terry J. Fry, Crystal L. Mackall
    Pages 397-414
  4. The Therapeutic Use of Natural-Killer Cells in Hematological Malignancies

    • Sherif S. Farag, Michael A. Caligiuri
    Pages 415-432
  5. Antibody Therapy for Solid Tumors

    • Cristina I. Truica, Dorinda Rouch, Carlos L. Arteaga
    Pages 433-444
  6. Antibody Therapy for Non-Hodgkin’s Lymphoma

    • Stephen M. Ansell, Thomas E. Witzig
    Pages 445-455
  7. Approaches to In Vivo Imaging of Cancer Immunotherapy

    • George A. Vielhauer, Bond Almand, Mary L. Disis, David A. Mankoff, Keith L. Knutson
    Pages 457-477
  8. Monoclonal Antibody Therapy of Cancer

    • Hossein Borghaei, Matthew K. Robinson, Louis M. Weiner
    Pages 487-502
  9. Back Matter

    Pages 503-516

About this book

Expert bench and clinical scientists join forces to concurrently review both the state-of-the-art in tumor immunology and its clinical translation into promising practical treatments. The authors explain in each chapter the scientific basis behind such therapeutic agents as monoclonal antibodies, cytokines, vaccines, and T-cells, and illustrate their clinical manipulation to combat cancer. Additional chapters address statistical analysis-both of clinical trials and assay evaluations-methods for the discovery of antigens, adoptive T cell therapy, and adaptive and innate immunity. The challenges in clinical trial design, the need for biomarkers of response-such as novel imaging techniques and immunologic monitoring-and the new advances and directions in cancer immunotherapy are also fully examined.

Reviews

From the reviews:

"Immunotherapy of Cancer provides in 28 chapters a comprehensive overview of experimental and clinical achievements in tumor immunology. Each chapter is designed to give the reader the scientific basis behind the discussed therapy and outline basic theory, as well as practical treatment applications. … The book belongs to the successful series of publications Cancer Drug Discovery and Development from Humana Press. It will be of interest to clinicians and to laboratory cancer researchers … ." (Cestmir Altaner, Neoplasma, Vol. 54 (2), March, 2007)

Editors and Affiliations

  • University of Washington School of Medicine, Seattle

    Mary L. Disis

Bibliographic Information

Buy it now

Buying options

eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access